Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk assessment and genetic testing for ovarian cancer.

AJR. American journal of roentgenology - 1 Feb 2010

Gulden Cassandra, Olopade Olufunmilayo I

Abstract excerpt

OBJECTIVE: Prevention of ovarian cancer starts with identifying women at high risk for this deadly disease. Once identified, these women can be offered risk-reducing options such as oral contraceptives and bilateral salpingo-oophorectomy. In this review, strategies for identifying high-risk individuals and the clinical utility of genetic testing for BRCA1 and BRCA2 will be discussed. CONCLUSION: To offer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 gene
Share to BRCA2 gene
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Testing

Share to Mutation

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Identifiers

PMID: 20093589
DOI: 10.2214/AJR.09.3999

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk assessment and genetic testing for ovarian cancer.PMID 20093589Read ↗

Risk assessment & genetic testing.Semantic proximity Read ↗

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.Semantic proximity Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.Semantic proximity Read ↗

Breast and ovarian cancer genetics and prevention.Semantic proximity Read ↗

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.Semantic proximity Read ↗

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

AGO Austria recommendations for genetic testing of patients with ovarian cancer.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Genetic risk assessment for breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.